Literature DB >> 25851969

[How to improve the diagnosis rate of early gastric cancer in China].

Wen-Bin Zou1, Fan Yang1, Zhao-Shen Li1.   

Abstract

China has great burden of gastric cancer, and the diagnosis rate of early gastric cancer is relatively low (<10%). To perform screening, early endoscopic diagnosis and treatment of gastric cancer in high-risk population is a feasible and efficient way to change the current status. Therefore, the Chinese Society of Digestive Endoscopy recently issued Consensus on screening, "Endoscopic diagnosis and treatment of early gastric cancer screening in China". The consensus suggests a feasible and efficient strategy for early detection of gastric cancer: screening with non-invasive procedures, followed by intensive endoscopic examination for screened high-risk population. In this article, we also describe the current status, the causes, high-risk population and early diagnosis of gastric cancer in China; and review the new development of serology and endoscopic techniques for early diagnosis.

Entities:  

Mesh:

Year:  2015        PMID: 25851969     DOI: 10.3785/j.issn.1008-9292.2015.01.002

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  10 in total

1.  Plasma lncRNA-GACAT2 is a valuable marker for the screening of gastric cancer.

Authors:  Lin Tan; Yunben Yang; Yongfu Shao; Haiqiang Zhang; Junming Guo
Journal:  Oncol Lett       Date:  2016-10-19       Impact factor: 2.967

2.  Establish a Scoring Model for High-Risk Population of Gastric Cancer and Study on the Pattern of Opportunistic Screening.

Authors:  Wei Tao; Hai-Xia Wang; Yu-Feng Guo; Li Yang; Peng Li
Journal:  Gastroenterol Res Pract       Date:  2020-09-30       Impact factor: 2.260

Review 3.  HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.

Authors:  Guo-Dong Cao; Ke Chen; Mao-Ming Xiong; Bo Chen
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

4.  Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.

Authors:  Guo-Dong Cao; Xing-Yu Xu; Jia-Wei Zhang; Bo Chen; Mao-Ming Xiong
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

5.  Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.

Authors:  Bin Song; Juan Du; De-Feng Song; Ji-Chen Ren; Ye Feng
Journal:  Biol Res       Date:  2018-11-03       Impact factor: 5.612

6.  National trend of gastric cancer mortality in China (2003-2015): a population-based study.

Authors:  Kun Gao; Jun Wu
Journal:  Cancer Commun (Lond)       Date:  2019-05-02

7.  ICAM1 Regulates the Development of Gastric Cancer and May Be a Potential Biomarker for the Early Diagnosis and Prognosis of Gastric Cancer.

Authors:  Songda Chen; Shan Pan; Huijie Wu; Jingyuan Zhou; Yueli Huang; Shuai Wang; Aiqun Liu
Journal:  Cancer Manag Res       Date:  2020-03-02       Impact factor: 3.989

8.  The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.

Authors:  Hongzhang Shen; Kangwei Xiong; Xiangyu Wu; Sile Cheng; Qifeng Lou; Hangbin Jin; Xiaofeng Zhang
Journal:  Gastroenterol Res Pract       Date:  2021-04-12       Impact factor: 2.260

9.  Cancer Burden in China during 1990-2019: Analysis of the Global Burden of Disease.

Authors:  Shu-Zhen Zhang; Li Zhang; Long Xie
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

10.  Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.

Authors:  Shuyan Zhang; Shanshan Li; Jian-Lin Guo; Ningyi Li; Cai-Ning Zhang; Jie Liu
Journal:  Dis Markers       Date:  2021-09-20       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.